Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Temporal DNA-PK activation drives genomic instability and therapy resistance in glioma stem cells.

Wang Y, Xu H, Liu T, Huang M, Butter PP, Li C, Zhang L, Kao GD, Gong Y, Maity A, Koumenis C, Fan Y.

JCI Insight. 2018 Feb 8;3(3). pii: 98096. doi: 10.1172/jci.insight.98096. [Epub ahead of print]

2.

Circulating Tumor Cells, DNA, and mRNA: Potential for Clinical Utility in Patients With Melanoma.

Xu MJ, Dorsey JF, Amaravadi R, Karakousis G, Simone CB 2nd, Xu X, Xu W, Carpenter EL, Schuchter L, Kao GD.

Oncologist. 2016 Jan;21(1):84-94. doi: 10.1634/theoncologist.2015-0207. Epub 2015 Nov 27. Review.

3.

A novel approach for the detection and genetic analysis of live melanoma circulating tumor cells.

Xu MJ, Cooke M, Steinmetz D, Karakousis G, Saxena D, Bartlett E, Xu X, Hahn SM, Dorsey JF, Kao GD.

PLoS One. 2015 Mar 25;10(3):e0123376. doi: 10.1371/journal.pone.0123376. eCollection 2015.

4.

Tracking viable circulating tumor cells (CTCs) in the peripheral blood of non-small cell lung cancer (NSCLC) patients undergoing definitive radiation therapy: pilot study results.

Dorsey JF, Kao GD, MacArthur KM, Ju M, Steinmetz D, Wileyto EP, Simone CB 2nd, Hahn SM.

Cancer. 2015 Jan 1;121(1):139-49. doi: 10.1002/cncr.28975. Epub 2014 Sep 19.

5.

Application of a telomerase-based circulating tumor cell (CTC) assay in bladder cancer patients receiving postoperative radiation therapy: a case study.

Ju M, Kao GD, Steinmetz D, Chandrasekaran S, Keefe SM, Guzzo TJ, Christodouleas JP, Hahn SM, Dorsey JF.

Cancer Biol Ther. 2014 Jun 1;15(6):683-7. doi: 10.4161/cbt.28412. Epub 2014 Mar 11.

6.

Detection of brain tumor cells in the peripheral blood by a telomerase promoter-based assay.

Macarthur KM, Kao GD, Chandrasekaran S, Alonso-Basanta M, Chapman C, Lustig RA, Wileyto EP, Hahn SM, Dorsey JF.

Cancer Res. 2014 Apr 15;74(8):2152-9. doi: 10.1158/0008-5472.CAN-13-0813. Epub 2014 Feb 13.

7.

Theranostic gold nanoparticles modified for durable systemic circulation effectively and safely enhance the radiation therapy of human sarcoma cells and tumors.

Joh DY, Kao GD, Murty S, Stangl M, Sun L, Al Zaki A, Xu X, Hahn SM, Tsourkas A, Dorsey JF.

Transl Oncol. 2013 Dec 1;6(6):722-31. eCollection 2013 Dec 1.

8.

Gold nanoparticles in radiation research: potential applications for imaging and radiosensitization.

Dorsey JF, Sun L, Joh DY, Witztum A, Kao GD, Alonso-Basanta M, Avery S, Hahn SM, Al Zaki A, Tsourkas A.

Transl Cancer Res. 2013 Aug 1;2(4):280-291.

9.

Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization.

Joh DY, Sun L, Stangl M, Al Zaki A, Murty S, Santoiemma PP, Davis JJ, Baumann BC, Alonso-Basanta M, Bhang D, Kao GD, Tsourkas A, Dorsey JF.

PLoS One. 2013 Apr 30;8(4):e62425. doi: 10.1371/journal.pone.0062425. Print 2013.

10.

Enhancing the efficacy of drug-loaded nanocarriers against brain tumors by targeted radiation therapy.

Baumann BC, Kao GD, Mahmud A, Harada T, Swift J, Chapman C, Xu X, Discher DE, Dorsey JF.

Oncotarget. 2013 Jan;4(1):64-79.

11.

Stereotactic intracranial implantation and in vivo bioluminescent imaging of tumor xenografts in a mouse model system of glioblastoma multiforme.

Baumann BC, Dorsey JF, Benci JL, Joh DY, Kao GD.

J Vis Exp. 2012 Sep 25;(67). pii: 4089. doi: 10.3791/4089.

12.

An integrated method for reproducible and accurate image-guided stereotactic cranial irradiation of brain tumors using the small animal radiation research platform.

Baumann BC, Benci JL, Santoiemma PP, Chandrasekaran S, Hollander AB, Kao GD, Dorsey JF.

Transl Oncol. 2012 Aug;5(4):230-7. Epub 2012 Aug 1.

13.

A 10-year analysis of American Society For Radiation Oncology Junior Faculty Career Development Awards.

Kimple RJ, Kao GD; Research Evaluation Committee of the ASTRO Research Council.

Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):924-8. doi: 10.1016/j.ijrobp.2012.07.2361. Epub 2012 Aug 25.

PMID:
22929862
14.

A role for the histone deacetylase HDAC4 in the life-cycle of HIV-1-based vectors.

Smith JA, Yeung J, Kao GD, Daniel R.

Virol J. 2010 Sep 16;7:237. doi: 10.1186/1743-422X-7-237.

15.

Lack of compliance with national vaccination guidelines in oncology patients receiving radiation therapy.

Yee SS, Dutta PR, Solin LJ, Vapiwala N, Kao GD.

J Support Oncol. 2010 Jan-Feb;8(1):28-34.

PMID:
20235421
16.

Modulation of the anti-cancer efficacy of microtubule-targeting agents by cellular growth conditions.

Dorsey JF, Dowling ML, Kim M, Voong R, Solin LJ, Kao GD.

Cancer Biol Ther. 2010 May 15;9(10):809-18.

17.

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells.

Dorsey JF, Mintz A, Tian X, Dowling ML, Plastaras JP, Dicker DT, Kao GD, El-Deiry WS.

Mol Cancer Ther. 2009 Dec;8(12):3285-95. doi: 10.1158/1535-7163.MCT-09-0415.

18.

The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer.

Crisanti MC, Wallace AF, Kapoor V, Vandermeers F, Dowling ML, Pereira LP, Coleman K, Campling BG, Fridlender ZG, Kao GD, Albelda SM.

Mol Cancer Ther. 2009 Aug;8(8):2221-31. doi: 10.1158/1535-7163.MCT-09-0138. Epub 2009 Aug 11.

19.

Mitotic checkpoint, aneuploidy and cancer.

Yen TJ, Kao GD.

Adv Exp Med Biol. 2005;570:477-99. doi: 10.1007/1-4020-3764-3_17. Review. No abstract available.

PMID:
18727512
20.

HDAC4 promotes growth of colon cancer cells via repression of p21.

Wilson AJ, Byun DS, Nasser S, Murray LB, Ayyanar K, Arango D, Figueroa M, Melnick A, Kao GD, Augenlicht LH, Mariadason JM.

Mol Biol Cell. 2008 Oct;19(10):4062-75. doi: 10.1091/mbc.E08-02-0139. Epub 2008 Jul 16.

Supplemental Content

Loading ...
Support Center